Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?
When Archie Cochrane reproached the medical profession for not having critical summaries of all randomised controlled trials, about 14 reports of trials were being published per day. There are now 75 trials, and 11 systematic reviews of trials, per day and a plateau in growth has not yet been reached. Although trials, reviews, and health technology assessments have undoubtedly had major impacts, the staple of medical literature synthesis remains the non-systematic narrative review. Only a small minority of trial reports are being analysed in up-to-date systematic reviews. Given the constraints, Archie Cochrane's vision will not be achieved without some serious changes in course. To meet the needs of patients, clinicians, and policymakers, unnecessary trials need to be reduced, and systematic reviews need to be prioritised. Streamlining and innovation in methods of systematic reviewing are necessary to enable valid answers to be found for most patient questions. Finally, clinicians and patients require open access to these important resources.
Bastian
Hilda
H
German Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany. Hilda.bastian@iqwig.de
Glasziou
Paul
P
Chalmers
Iain
I
D020811:Biomedical Technology; D019317:Evidence-Based Medicine / Q000639:trends; D006801:Humans; D011050:Policy Making; D011643:Publishing; D016032:Randomized Controlled Trials as Topic / Q000639:trends; D012196:Review Literature as Topic